Japan - English - すりの適正使用協議会 RAD-AR Council, Japan

nitto medic co., ltd. - brimonidine tartrate - clear and slightly greenish-yellow to distinctly greenish-yellow ophthalmic solution, 5 ml, (cap) greenish pale blue, (label) white label with greenish pale blue and dark green line, (bottle) green

Japan - English - すりの適正使用協議会 RAD-AR Council, Japan

santen pharmaceutical co.,ltd. - brimonidine tartrate - faint yellow green to yellow green, limpid, ophthalmic solution, 5ml, (bottle) green, (cap) white [label of gray wave design]

Belgium - English - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

sandoz sa-nv - brimonidine tartrate 2 mg/ml - eq. brimonidine 1,3 mg/ml; timolol maleate 6,8 mg/ml - eq. timolol 5 mg/ml - eye drops, solution - 2 mg/ml - 5 mg/ml - brimonidine tartrate 2 mg/ml; timolol maleate 6.8 mg/ml - timolol

United States - English - NLM (National Library of Medicine)

walgreens company - brimonidine tartrate (unii: 4s9cl2dy2h) (brimonidine - unii:e6gnx3hhte) - redness reliever • relieves redness of the eye due to minor eye irritations • if solution changes color or becomes cloudy - you experience eye pain, changes in vision, continued redness or irritation of the eye - condition worsens or persists for more than 3 days

Malta - English - Medicines Authority

allergan pharmaceuticals ireland castlebar road, westport, county mayo, ireland - brimonidine tartrate, timolol - eye drops, solution - brimonidine tartrate 2 mg/ml timolol 5 mg/ml - ophthalmologicals

United States - English - NLM (National Library of Medicine)

novartis pharmaceuticals corporation - brinzolamide (unii: 9451z89515) (brinzolamide - unii:9451z89515), brimonidine tartrate (unii: 4s9cl2dy2h) (brimonidine - unii:e6gnx3hhte) - simbrinza (brinzolamide and brimonidine tartrate ophthalmic suspension) 1% and 0.2% is a fixed combination of a carbonic anhydrase inhibitor and an alpha-2 adrenergic receptor agonist indicated for the reduction of elevated intraocular pressure (iop) in patients with open-angle glaucoma or ocular hypertension. simbrinza is contraindicated in patients who are hypersensitive to any component of this product. simbrinza is contraindicated in neonates and infants (under the age of two years) [see use in specific populations (8.4)] . pregnancy category c: developmental toxicity studies with brinzolamide in rabbits at oral doses of 1, 3, and 6 mg/kg/day (20, 60, and 120 times the recommended human ophthalmic dose) produced maternal toxicity at 6 mg/kg/day and a significant increase in the number of fetal variations, such as accessory skull bones, which was only slightly higher than the historic value at 1 and 6 mg/kg. in rats, statistically decreased body weights of fetuses from dams receiving oral doses of 18 mg/k

Israel - English - Ministry of Health

abbvie biopharmaceuticals ltd, israel - brimonidine tartrate; timolol as maleate - eye drops solution - timolol as maleate 0.5 %w/v; brimonidine tartrate 0.2 %w/v - brimonidine - brimonidine - combigan is indicated for lowering intraocular pressure in patients with open-angle glaucoma or ocular hypertension.

Canada - English - Health Canada

teva canada limited - brimonidine tartrate - solution - 0.2% - brimonidine tartrate 0.2% - alpha-adrenergic agonists

Canada - English - Health Canada

apotex inc - brimonidine tartrate - solution - 0.2% - brimonidine tartrate 0.2% - alpha-adrenergic agonists

Canada - English - Health Canada

sandoz canada incorporated - brimonidine tartrate - solution - 0.2% - brimonidine tartrate 0.2% - alpha-adrenergic agonists